The Bid & Ask

Quotations, Dispatches, and the Daily Tape

Thursday, August 13, 2026

Subject of the day

AVTR

Concerning the House

Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, peristaltic pumps, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, compound management, cleanroom control, monitoring, maintenance, and sanitization services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.

United States · www.avantorsciences.com

The Long Run

FY 2019–2025 · 6 years

LineLatestCAGRTrend
Revenue$6.55B+34.2%
Gross profit$2.14B+37.2%
Operating income$696.40M+4.8%
Net income$321.10M+53.4%
Cash from ops$840.80M+18.9%
Quotation

$13.85

-0.08 (-0.6%)

52w hi$15.60
52w lo$7.41
Vol4.63M
As ofAug 13
The Verdict

Hold

Our score -0.12

Short-0.00
Medium-0.02
Long-0.56

computed 2026-08-13

By the Numbers

Avantor, Inc.

Healthcare · Medical Instruments & Supplies

Market cap$9.37B
Enterprise value$12.81B
Trailing P/E
Forward P/E15.71x
EV / EBITDA13.32x
P / S (ttm)1.43x
Profit margin-8.8%
Return on equity-9.7%
Revenue growth+0.5%
Earnings growth-37.4%
Debt / equity65.68
Risk Metrics
Beta vs SPX1.05
Corr SPX0.35
Annual vol48.6%
Annual ret-18.4%
Sharpe-0.38
Max DD-73.2%

Window: 504 trading days (504 obs)

Layer Breakdown
LayerRawContribution
Fundamental-0.13
Sector+0.12
Technical+0.00
Earnings+0.00
Sentiment+0.00

macro × 1.00 · 2026-08-13

Recent Sessions
DateOpenHighLowCloseVol
Aug 13$13.98$14.02$13.66$13.854.63M
Aug 12$13.57$13.94$13.42$13.936.20M
Aug 11$13.65$13.81$13.547.64M
Aug 10$13.50$13.79$13.40$13.736.43M
Aug 7$13.33$13.59$13.23$13.596.22M